H71 H65 H66 H74 H90
Conditions
Interventions
Group 1: Tympanoplasty Type II, III and IV
Sponsors
Klinik für Hals-Nasen-Ohrenheilkunde Universitätsklinikum Freiburg
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients who have received a tympanoplasty type II, III or IV at the Department of Oto- Rhino- Laryngology at the University of Freiburg in the period 2012 to 2019 will be included.
Exclusion criteria
Exclusion criteria: Excluded are patients with operations on the respective ear that took place before 2012 or outside the university hospital. In addition, the surgical indications meningo- and encephalocele, paraganglioma of the tympanic cavity, meningitis with focus at the ear and tympanoplasty as a preparation to a cochlear implant are excluded, as these underlying diseases would falsify an objective comparison of the hearing results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in hearing after tympanoplasty type II, III and IV | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the number of retympanoplasties; Evaluation of the number of recurrent cholesteatoms in retympanoplasty; Evaluation of the hearing ability depending on the implanted prosthesis type (PORP/TORP/Clip/Winkel etc.); Dependence of retympanoplasty on the age of the patients; dependence of the number of retympanoplasties on gender; dependence of hearing success on gender; dependence of hearing success on smoking status; dependence of hearing success on MER- and OOPS-index; | — |
Countries
Germany
Contacts
Public ContactSusan Arndt
Klinik für Hals-Nasen-Ohrenheilkunde Universitätsklinikum Freiburg
Outcome results
None listed